- Home
- APM vs PAVM Comparison
APM vs PAVM Comparison
Compare APM & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- PAVM
- Stock Information
- Founded
- APM 2010
- PAVM 2014
- Country
- APM United Kingdom
- PAVM United States
- Employees
- APM N/A
- PAVM N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- APM Health Care
- PAVM Health Care
- Exchange
- APM Nasdaq
- PAVM Nasdaq
- Market Cap
- APM 6.9M
- PAVM 8.0M
- IPO Year
- APM 2018
- PAVM 2016
- Fundamental
- Price
- APM $1.42
- PAVM $0.46
- Analyst Decision
- APM
- PAVM Strong Buy
- Analyst Count
- APM 0
- PAVM 1
- Target Price
- APM N/A
- PAVM $19.00
- AVG Volume (30 Days)
- APM 461.1K
- PAVM 250.8K
- Earning Date
- APM 08-19-2025
- PAVM 08-14-2025
- Dividend Yield
- APM N/A
- PAVM N/A
- EPS Growth
- APM N/A
- PAVM N/A
- EPS
- APM N/A
- PAVM 0.96
- Revenue
- APM N/A
- PAVM $1,993,000.00
- Revenue This Year
- APM N/A
- PAVM N/A
- Revenue Next Year
- APM N/A
- PAVM $455.63
- P/E Ratio
- APM N/A
- PAVM $0.48
- Revenue Growth
- APM N/A
- PAVM N/A
- 52 Week Low
- APM $0.46
- PAVM $0.30
- 52 Week High
- APM $7.49
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- APM 51.44
- PAVM 35.35
- Support Level
- APM $1.21
- PAVM $0.43
- Resistance Level
- APM $1.44
- PAVM $0.53
- Average True Range (ATR)
- APM 0.13
- PAVM 0.05
- MACD
- APM -0.04
- PAVM -0.01
- Stochastic Oscillator
- APM 34.37
- PAVM 52.70
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.